drugset / Trial / NCT02143570

Efficacy of Darifenacin and Physiotherapy for the Treatment of Overactive Bladder in Women

NCT02143570

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Overactive bladder is a common problem among adult women. Darifenacin is an antimuscarinic drug that is frequently used as part of the management of the condition. However, current evidence backing its use is limited. This study aims to address Darifenacin's effectiveness in adjunct to physiotherapy in treating symptoms due to overactive bladder.

Timeline

Start
2014-05
Primary completion
2016-04
Completion
2016-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Darifenacin Small molecule 7.5 mg
Subject Darifenacin Small molecule 15 mg

Indications